{
    "id": 27002,
    "fullName": "NAPRT negative",
    "impact": "unknown",
    "proteinEffect": "loss of function",
    "geneVariantDescriptions": [
        {
            "description": "NAPRT negative indicates a lack of the NAPRT1 gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 93100,
        "geneSymbol": "NAPRT",
        "terms": [
            "NAPRT",
            "NAPRT1",
            "PP3856"
        ]
    },
    "variant": "negative",
    "createDate": "09/19/2017",
    "updateDate": "10/01/2017",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 11994,
            "approvalStatus": "Phase I",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase I trial, 50% (2/4) of advanced solid tumor patients who achieved stable disease after KPT-9274 treatment were Naprt negative (Ann Oncol 2017, Vol 28, Suppl 5, Abstract # 374PD; NCT02702492).",
            "molecularProfile": {
                "id": 28370,
                "profileName": "NAPRT negative"
            },
            "therapy": {
                "id": 4662,
                "therapyName": "KPT-9274",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 9951,
                    "pubMedId": null,
                    "title": "A first in human phase 1 study of KPT-9274, a first in class dual inhibitor of PAK4 and NAMPT, in patients with advanced solid malignancies or NHL",
                    "url": "http://www.esmo.org/content/download/117241/2057634/file/ESMO-2017-Abstract-Book.pdf"
                }
            ],
            "ampCapAscoEvidenceLevel": "C",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 28370,
            "profileName": "NAPRT negative",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}